This study verified that Yangxinshi's role in reversing CF in DCM by regulating CBL pathway by analyzing network pharmacology of selecting the key biological mechanism about the intervention of Yangxinshi. The gene discussed is CBL; the disease is familial dilated cardiomyopathy.